This Advisory from the Substance Abuse and Mental Health Services Administration provides detailed guidance for taking medications for opioid use disorder (OUD) during pregnancy. It also describes barriers to such treatment, including stigma, and calls for service providers to prioritize health equity for underserved pregnant people with OUD who are in critical need of culturally responsive and empathetic care.